Trupti Trivedi, a former executive with GlaxoSmithKline Plc, has joined Adaptimmune Therapeutics Plc as head of biometrics with responsibility for data management and computational programming across all of the company’s clinical development programmes. Adaptimmune is developing cancer immunotherapies based on a T-cell receptor platform.
Also joining the company are Michael Blackton as head of quality assurance and chemistry, manufacturing and controls and Joseph Apostolico as director of human resources. Mr Blackton comes to Adaptimmune from Eli Lilly and Company. Mr Apostolico previously worked at GSK for 28 years. Adaptmmune has a licensing and collaboration agreement with GSK.
Adaptimmune announced the appointment on 9 September 2015.
Copyright 2015 Evernow Publishing Ltd